Erbitux
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.erbitux.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Erbitux
Eli Lilly and Company offers ERBITUX (cetuximab), a treatment specifically designed for patients with metastatic colorectal cancer and certain types of head and neck cancers. This drug functions as an epidermal growth factor receptor (EGFR) inhibitor, aiming to block cancer cell growth and trigger an immune response against tumors. The intended clients include individuals diagnosed with advanced colorectal cancer and head and neck cancer, particularly those with specific genetic markers. ERBITUX is available by prescription and is supported by comprehensive information for both patients and healthcare providers.Explore more
Popular SearchesErbituxSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Erbitux your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Erbitux recently announced quarterly report
Check out if Erbitux is spiking on competitors!
Check if Erbitux has recently received funding, and reach out quickly before it becomes old news!
Erbitux, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Erbitux had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Erbitux
Funding: Get notified immidiatlly once Erbitux has new funding data
Product Launch: Get notified when Erbitux launches new products
Recommended Actions
Find VP level buyers at Erbitux
Find 2 more new buyers
Compare Similar Companies to Erbitux
Compare insights from companies similar to Erbitux, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Erbitux
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Erbitux is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Erbitux is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Erbitux.
Erbitux Tech Stack
A closer look at the technologies used by Erbitux
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Erbitux
Sign Up For FreeTo access detailed company insights
Eli Lilly and Company offers ERBITUX (cetuximab), a treatment specifically designed for patients with metastatic colorectal cancer and certain types of head and neck cancers. This drug functions as an epidermal growth factor receptor (EGFR) inhibitor, aiming to block cancer cell growth and trigger an immune response against tumors. The intended cli... Read More
